Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-NSCC): Results from the randomized phase II RESGEX study.

被引：4
|
作者：
Keilholz, Ulrich
Kawecki, Andrzej
Dietz, Andreas
Zurawski, Bogdan
Schenker, Michael
Kukielka-Budny, Bozena
Schafhausen, Philippe
Mihailov, Anca C.
Ochenduszko, Sebastian
Imarisio, Ilaria
Mihutiu, Simona
Oprean, Cristina-Marinela
Folprecht, Gunnar
Turcu, Alina
Rottey, Sylvie
Debourdeau, Philippe
Lavernia, Javier
Dietrich, Bruno
Zurlo, Alfredo
Fayette, Jerome
机构：
[1] Charite Comprehens Canc Ctr, Berlin, Germany
[2] M Sklodowska Curie Mem Inst, Canc Ctr, Warsaw, Poland
[3] Univ Leipzig, Leipzig, Germany
[4] F Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[5] S C Centrul Oncol, Policlin Sf Nectarie, Craiova, Romania
[6] Ctr Oncol, Lublin, Poland
[7] Univ Hamburg Eppendorf, Hamburg, Germany
[8] Univ Hosp Cluj, Cluj Napoca, Romania
[9] Krakow Univ Hosp Oncol Clin, Krakow, Poland
[10] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, Pavia, Italy
[11] Emergency Clin Hosp Oradea, Oradea, Bihor, Romania
[12] ONCOMED SRL, Timisoara, Romania
[13] Univ Hosp Carl Gustav Carus, Dresden, Germany
[14] SPITAL LOTUS SRL, Ploiesti, Romania
[15] Ghent Univ Hosp, Heymans Inst Pharmacol, Ghent, Belgium
[16] Inst Sainte Catherine, Avignon, France
[17] FIVO, Valencia, Spain
[18] Glycotope GmbH, Berlin, Germany
[19] Ctr Leon Berard, Med Oncol, Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
59
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [22] Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II study.
    Trigo, J
    Hitt, R
    Koralewski, P
    Diaz-Rubio, E
    Rolland, F
    Knecht, R
    Amellal, N
    Bessa, EH
    Baselga, J
    Vermorken, JB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 488S - 488S
  • [23] Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study.
    Chung, Christine H.
    Bonomi, Marcelo Raul
    Steuer, Conor Ernst
    Schell, Michael J.
    Li, Jiannong
    Johnson, Matthew
    Masannat, Jude
    Hernandez-Prera, Juan C.
    McMullen, Caitlin
    Wadsworth, J.
    Patel, Krupal
    Kish, Julie Ann
    Muzaffar, Jameel
    Kirtane, Kedar
    Rocco, James William
    Saba, Nabil F.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial
    Tamaskovics, B. F.
    Hecht, M.
    Schubert, P.
    Kallies, A.
    Illmer, T.
    Radke, J.
    Koelbl, O.
    Steger, F.
    Brunner, T. B.
    Roedel, C.
    Fleischmann, M.
    Reinacher-Schick, A.
    Wingender, L. F.
    Melchior, P.
    Klautke, G.
    Hintzen, U.
    Gaipl, U. S.
    Haussmann, J.
    Budach, W.
    Fietkau, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S593 - S593
  • [25] A phase II study of ispinesib in patients (PTS) with recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSC)
    Tang, Patricia
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Colevas, A. Dimitrios
    Johnson, Caitlin
    Pond, Greg R.
    Winquist, Eric
    ANNALS OF ONCOLOGY, 2006, 17 : 186 - 186
  • [26] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    CANCER, 2001, 91 (07) : 1316 - 1323
  • [27] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
  • [28] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [29] Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck - A phase II multicenter study
    Labourey, Jean-Luc
    Cupissol, Didier
    Calais, Gilles
    Tourani, Jean-Marc
    Kohser, Frederic
    Borel, Christian
    Eymard, Jean-Christophe
    Germann, Nathalie
    Tubiana-Mathieu, Nicole
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 278 - 282
  • [30] Gemcitabine and paclitaxel in metastatic or recurrent squamous cell carcinoma of the head and neck: a phase I-II study
    Stier, S
    Koll, C
    Neuhaus, T
    Fronhoffs, S
    Forkert, R
    Tuohimaa, A
    Vetter, H
    Ko, Y
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1115 - 1121
12345